Manna Research, Inc.

Toronto, Ontario M9W 4L6

0 studies enrolling now · 3 studies all time

What they study most

Clostridium Difficile, Hyperlipidemia, Post Herpetic Neuralgia

Studies at this site

• A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine. — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia — Completed